Emerging strategies in stimuli-responsive prodrug nanosystems for cancer therapy

C Ding, C Chen, X Zeng, H Chen, Y Zhao - ACS nano, 2022 - ACS Publications
Prodrugs are chemically modified drug molecules that are inactive before administration.
After administration, they are converted in situ to parent drugs and induce the mechanism of …

Designing hydrogels for immunomodulation in cancer therapy and regenerative medicine

Z Zhang, C He, X Chen - Advanced Materials, 2024 - Wiley Online Library
The immune system not only acts as a defense against pathogen and cancer cells, but also
plays an important role in homeostasis and tissue regeneration. Targeting immune systems …

Oxidative stress in the tumor microenvironment and its relevance to cancer immunotherapy

NS Aboelella, C Brandle, T Kim, ZC Ding, G Zhou - Cancers, 2021 - mdpi.com
Simple Summary Cancer cells are consistently under oxidative stress, as reflected by
elevated basal level of reactive oxygen species (ROS), due to increased metabolism driven …

[HTML][HTML] Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy

S Yin, Z Chen, D Chen, D Yan - Theranostics, 2023 - ncbi.nlm.nih.gov
Immunotherapy has achieved great success recently and opened a new avenue for anti-
tumor treatment. Programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) …

Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway

L Cheng, P Zhang, Y Liu, Z Liu, J Tang, L Xu, J Liu - Biomaterials, 2023 - Elsevier
Due to the immunosuppressive tumor microenvironment (ITM) resulting from tumor-
associated macrophages (TAMs) and regulatory T cells, immune checkpoint blockade and …

Camptothecin-based prodrug nanomedicines for cancer therapy

R Zhang, J Yu, Z Guo, H Jiang, C Wang - Nanoscale, 2023 - pubs.rsc.org
Camptothecin (CPT) is a cytotoxic alkaloid that attenuates the replication of cancer cells via
blocking DNA topoisomerase 1. Despite its encouraging and wide-spectrum antitumour …

[HTML][HTML] Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy

S Han, J Wu - Bioactive Materials, 2022 - Elsevier
Though increasing understanding and remarkable clinical successes have been made,
enormous challenges remain to be solved in the field of cancer immunotherapy. In this …

Stimuli‐responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy

W Xu, W Liu, J Yang, J Lu, H Zhang… - Immunological …, 2024 - Wiley Online Library
Immunogenic cell death (ICD) is a special pattern of tumor cell death, enabling to elicit tumor‐
specific immune response via the release of damage‐associated molecular patterns and …

Development and challenges of antimicrobial peptide delivery strategies in bacterial therapy: A review

L Yao, Q Liu, Z Lei, T Sun - International Journal of Biological …, 2023 - Elsevier
The escalating global prevalence of antimicrobial resistance poses a critical threat,
prompting concerns about its impact on public health. This predicament is exacerbated by …

Cancer immunotherapy elicited by immunogenic cell death based on smart nanomaterials

M Yang, C Zhang, R Wang, X Wu, H Li… - Small Methods, 2023 - Wiley Online Library
Cancer immunotherapy has been a revolutionary cancer treatment modality because it can
not only eliminate primary tumors but also prevent metastases and recurrent tumors …